In preclinical models of visceral leishmaniasis, the impact of local oxygen levels on Nos2-mediated antileishmanial defense and NO production in the spleen and liver is, however, to the best of our knowledge unexplored. The gene discussed is NOS2; the disease is visceral leishmaniasis.